United States · FDA National Drug Code directory
Divalproex Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-533_86498fa3-61af-c27e-9f94-b2a3fb6e16df
- Product NDC
- 55111-533
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- Divalproex Sodium
- Labeler
- Dr. Reddy's Laboratories Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130811
- Source listing expiry
- 20271231
Source-listed ingredients
- DIVALPROEX SODIUM — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55111-533-01) · 55111-533-01
- 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55111-533-05) · 55111-533-05
- 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55111-533-30) · 55111-533-30
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55111-533-60) · 55111-533-60
- 10 BLISTER PACK in 1 CARTON (55111-533-78) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (55111-533-79) · 55111-533-78
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →